NCT05197543

Brief Summary

The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponing of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI diagnostic method in a quasi-prospective observational patient cohort study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 15, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 19, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

January 25, 2022

Status Verified

January 1, 2022

Enrollment Period

1.8 years

First QC Date

January 15, 2022

Last Update Submit

January 19, 2022

Conditions

Keywords

Abdominal aortic AneurysmBiomechanicsRupture riskPredictabilityCOVID-19

Outcome Measures

Primary Outcomes (1)

  • Test the clinical applicability of the BRRA method

    Identify the number of number of false positive and false negative cases assessed by BRRA method according to clinical data and compare these data to control group where the decision making process was based only on maximal diameter of AAA

    21 months

Secondary Outcomes (1)

  • Reduction of time required for AAA assessment

    21 months

Study Arms (2)

BRRA group

Rupture risk of asymptomatic AAAs in this group was estimated using Biomechanical rupture rist assessment (BRRA). BRRA considers an AAA as a pressure vessel and estimates its risk of rupture by comparing its wall stress to wall strength

Diagnostic Test: Biomechanical rupture risk assessment

Maximal diameter group

Rupture risk of asymptomatic AAAs in this group was estimated by a classical approach based on a maximal diameter.

Interventions

3D computational model is created from CT angiographic images available during standard AAA diagnostic process. Vascular wall stress is assessed based on the 3D model using Finite element method to identify highly stressed parts of AAA and results are compared to populational wall strength information (gathered from previous large histological study), thus rupture risk (stress/strength ratio) of each particular AAA is estimated. Other relevant factors such as gender, blood pressure, presence of intraluminal thrombus etc. are used during the calculation as well.

Also known as: Vascular wall stress assessment using finite element method
BRRA group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with asymptomatic AAA during the COVID-19 pandemic period. During this period an elective surgeries had to be posponed and there was a need for auxiliary diagnostic method able to identify AAAs with high risk of rupture.

You may qualify if:

  • presence of asymptomatic abdominal aortic aneurysm (AAA)
  • regular CT angiography scans available

You may not qualify if:

  • rupture of AAA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Anne´s University Hospital in Brno

Brno, 65691, Czechia

Location

MeSH Terms

Conditions

Aortic Aneurysm, AbdominalCOVID-19

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Robert Staffa, M.D., Ph.D.

    Masaryk University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invastigator

Study Record Dates

First Submitted

January 15, 2022

First Posted

January 19, 2022

Study Start

March 12, 2020

Primary Completion

December 17, 2021

Study Completion

March 1, 2022

Last Updated

January 25, 2022

Record last verified: 2022-01

Locations